Can anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progress
Several studies over the past decade have now consistently indicated that the serum anti-Mullerian hormone (AMH) levels are at least 2–3-fold higher in the patients with polycystic ovary syndrome (PCOS), which also corresponds to the increased number of AMH producing preantral and small antral folli...
Main Authors: | Awadhesh Kumar Singh, Ritu Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2015;volume=19;issue=6;spage=731;epage=743;aulast=Singh |
Similar Items
-
Serum Anti-Müllerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms
by: Nada Ahmed, et al.
Published: (2019-10-01) -
Anti-Müllerian hormone as a diagnostic marker in Egyptian infertile polycystic ovary syndrome females: Correlations with Vitamin D, total testosterone, dyslipidemia and anthropometric parameters
by: Bakeer Engy, et al.
Published: (2018-01-01) -
Anti-Müllerian hormone in polycystic ovary syndrome and normo-ovulatory women: Correlation with clinical, hormonal and ultrasonographic parameters
by: Adel F. Begawy, et al.
Published: (2010-10-01) -
Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent
by: Nathalie di Clemente, et al.
Published: (2022-10-01) -
The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups
by: Ran Y, et al.
Published: (2021-03-01)